4 analysts have expressed a variety of opinions on Ikena Oncology (NASDAQ:IKNA) over the past quarter, offering a diverse set of opinions from bullish to bearish.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $10.25, a high estimate of $11.00, and a low estimate of $8.00. Observing a downward trend, the current average is 6.82% lower than the prior average price target of $11.00.

Diving into Analyst Ratings: An In-Depth Exploration

In examining...